Shandong Jincheng Pharmaceutical Group Co., Ltd (SHE:300233)
China flag China · Delayed Price · Currency is CNY
15.12
-0.17 (-1.11%)
At close: Feb 13, 2026

SHE:300233 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
669.37917.671,025859.13981.181,075
Cash & Short-Term Investments
741.37917.671,025859.13981.181,075
Cash Growth
-21.24%-10.44%19.27%-12.44%-8.75%8.56%
Accounts Receivable
580.74696.8794.56803.39684790.05
Other Receivables
4.166.457.814.625.082.07
Receivables
584.9703.25802.37808.01689.08792.12
Inventory
528.47598.86501.28579.22391.32284.08
Prepaid Expenses
--0.20.550.011.37
Other Current Assets
39.9838.540.7761.2477.6869.04
Total Current Assets
1,8952,2582,3692,3082,1392,222
Property, Plant & Equipment
2,2202,3102,4682,4692,0931,777
Long-Term Investments
183.77183.28147.52141.22143.31129.39
Other Intangible Assets
513.75513.51547.29452.2449.75494.35
Long-Term Deferred Tax Assets
50.3863.9469.7751.9630.7140.93
Long-Term Deferred Charges
244.28252.96310.89369.59329.72286.79
Other Long-Term Assets
34.5623.53.5134.4289.7749.8
Total Assets
5,1415,6055,9165,8265,2755,000
Accounts Payable
435.06552.56824726.05515.31299.63
Accrued Expenses
181.63355.9402.32394.98362.19400.69
Short-Term Debt
120.0755.0494212.89223154
Current Portion of Long-Term Debt
91.67101.52109.24163.2155.45-
Current Portion of Leases
-0.130.721.112.37-
Current Income Taxes Payable
30.1321.5324.8518.8418.7218.83
Current Unearned Revenue
31.6250.9432.7444.6754.4735.03
Other Current Liabilities
194.4793.35112.47139.284.94240.73
Total Current Liabilities
1,0851,2311,6001,7011,4161,149
Long-Term Debt
163.34351.99346.7271.69208.29255.39
Long-Term Leases
5.766.883.462.0263.52-
Long-Term Unearned Revenue
53.9453.8861.66654.8151.41
Long-Term Deferred Tax Liabilities
113.94129.1122.94126.2192.6677.11
Other Long-Term Liabilities
2.03-----
Total Liabilities
1,4241,7732,1352,1671,8361,533
Common Stock
383.87383.87383.87387.41387.41391.55
Additional Paid-In Capital
2,3282,3282,3282,3972,4042,474
Retained Earnings
930.771,051967.95850.41653.34622.84
Treasury Stock
-55.01-55.01--56.94-80.01-73.55
Comprehensive Income & Other
62.8859.4934.6229.3329.4423.45
Total Common Equity
3,6503,7673,7143,6073,3943,438
Minority Interest
67.1965.1766.9351.8744.9629.32
Shareholders' Equity
3,7173,8323,7813,6593,4393,467
Total Liabilities & Equity
5,1415,6055,9165,8265,2755,000
Total Debt
380.83515.56554.12650.91652.62409.39
Net Cash (Debt)
360.54402.11470.54208.22328.55665.85
Net Cash Growth
4.35%-14.54%125.98%-36.62%-50.66%80.04%
Net Cash Per Share
0.921.061.210.540.851.72
Filing Date Shares Outstanding
379.33379.33383.87383.1383.87387.41
Total Common Shares Outstanding
379.33379.33383.87383.1383.87387.41
Working Capital
810.091,027768.95607.21722.831,073
Book Value Per Share
9.629.939.689.428.848.87
Tangible Book Value
3,1363,2533,1673,1552,9452,944
Tangible Book Value Per Share
8.278.588.258.247.677.60
Buildings
-1,4241,4061,3561,021946.46
Machinery
-2,4142,2892,1521,6711,388
Construction In Progress
-73.33148.97121.31332.32300.44
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.